
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies
Wilson I. Gonsalves, Vijay Ramakrishnan, Taro Hitosugi, et al.
JCI Insight (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 46
Wilson I. Gonsalves, Vijay Ramakrishnan, Taro Hitosugi, et al.
JCI Insight (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Glutamine reliance in cell metabolism
Hee Chan Yoo, Ya Chun Yu, Yulseung Sung, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 9, pp. 1496-1516
Open Access | Times Cited: 666
Hee Chan Yoo, Ya Chun Yu, Yulseung Sung, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 9, pp. 1496-1516
Open Access | Times Cited: 666
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Xian Li, Xueqiang Peng, Yan Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Xian Li, Xueqiang Peng, Yan Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
2-Hydroxyglutarate in Cancer Cells
Petr Ježek
Antioxidants and Redox Signaling (2019) Vol. 33, Iss. 13, pp. 903-926
Open Access | Times Cited: 104
Petr Ježek
Antioxidants and Redox Signaling (2019) Vol. 33, Iss. 13, pp. 903-926
Open Access | Times Cited: 104
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Shen‐Han Lee, Monika Golinska, John R. Griffiths
Cells (2021) Vol. 10, Iss. 9, pp. 2371-2371
Open Access | Times Cited: 99
Shen‐Han Lee, Monika Golinska, John R. Griffiths
Cells (2021) Vol. 10, Iss. 9, pp. 2371-2371
Open Access | Times Cited: 99
Glutamine Is Required for M1-like Polarization of Macrophages in Response to Mycobacterium tuberculosis Infection
Qingkui Jiang, Yunping Qiu, Irwin J. Kurland, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 51
Qingkui Jiang, Yunping Qiu, Irwin J. Kurland, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 51
Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells
Qiyin Zhou, Hua Li, Yuanyuan Li, et al.
JCI Insight (2019) Vol. 4, Iss. 4
Open Access | Times Cited: 69
Qiyin Zhou, Hua Li, Yuanyuan Li, et al.
JCI Insight (2019) Vol. 4, Iss. 4
Open Access | Times Cited: 69
Metabolic Features of Multiple Myeloma
Chaima El Arfani, Kim De Veirman, Ken Maes, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1200-1200
Open Access | Times Cited: 64
Chaima El Arfani, Kim De Veirman, Ken Maes, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1200-1200
Open Access | Times Cited: 64
Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect
Elizabeth K. Wiese, Sadae Hitosugi, Sharon T. Loa, et al.
Nature Metabolism (2021) Vol. 3, Iss. 7, pp. 954-968
Open Access | Times Cited: 44
Elizabeth K. Wiese, Sadae Hitosugi, Sharon T. Loa, et al.
Nature Metabolism (2021) Vol. 3, Iss. 7, pp. 954-968
Open Access | Times Cited: 44
Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma
Dustin Rizzieri, Barry Paul, Yubin Kang
Journal of Cancer Metastasis and Treatment (2019) Vol. 2019
Open Access | Times Cited: 51
Dustin Rizzieri, Barry Paul, Yubin Kang
Journal of Cancer Metastasis and Treatment (2019) Vol. 2019
Open Access | Times Cited: 51
Plasma cells: You are what you eat
Lucas J. D’Souza, Deepta Bhattacharya
Immunological Reviews (2019) Vol. 288, Iss. 1, pp. 161-177
Open Access | Times Cited: 49
Lucas J. D’Souza, Deepta Bhattacharya
Immunological Reviews (2019) Vol. 288, Iss. 1, pp. 161-177
Open Access | Times Cited: 49
Oncometabolite Fingerprinting Using Fluorescent Single‐Walled Carbon Nanotubes
Dean Amir, Adi Hendler‐Neumark, Verena Wulf, et al.
Advanced Materials Interfaces (2021) Vol. 9, Iss. 4
Closed Access | Times Cited: 34
Dean Amir, Adi Hendler‐Neumark, Verena Wulf, et al.
Advanced Materials Interfaces (2021) Vol. 9, Iss. 4
Closed Access | Times Cited: 34
Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia*
Lukas Janker, Rupert L. Mayer, Andrea Bileck, et al.
Molecular & Cellular Proteomics (2019) Vol. 18, Iss. 5, pp. 936a-953
Open Access | Times Cited: 39
Lukas Janker, Rupert L. Mayer, Andrea Bileck, et al.
Molecular & Cellular Proteomics (2019) Vol. 18, Iss. 5, pp. 936a-953
Open Access | Times Cited: 39
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment
Krisstina Gowin, Sheri Skerget, Jonathan J. Keats, et al.
Leukemia Research (2021) Vol. 111, pp. 106687-106687
Open Access | Times Cited: 30
Krisstina Gowin, Sheri Skerget, Jonathan J. Keats, et al.
Leukemia Research (2021) Vol. 111, pp. 106687-106687
Open Access | Times Cited: 30
Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders
Sridurga Mithraprabhu, Maoshan Chen, Ioanna Savvidou, et al.
Leukemia (2021) Vol. 35, Iss. 10, pp. 2771-2783
Closed Access | Times Cited: 26
Sridurga Mithraprabhu, Maoshan Chen, Ioanna Savvidou, et al.
Leukemia (2021) Vol. 35, Iss. 10, pp. 2771-2783
Closed Access | Times Cited: 26
Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs
Paula Saavedra-García, Mónica Román-Trufero, Hibah A. Al-Sadah, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 25
Paula Saavedra-García, Mónica Román-Trufero, Hibah A. Al-Sadah, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 25
Multiple myeloma metabolism – a treasure trove of therapeutic targets?
Mónica Román-Trufero, Holger W. Auner, Claire M. Edwards
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Mónica Román-Trufero, Holger W. Auner, Claire M. Edwards
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment
María Matamala Montoya, Gijs J. J. van Slobbe, Jung‐Chin Chang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
María Matamala Montoya, Gijs J. J. van Slobbe, Jung‐Chin Chang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Lipid metabolic vulnerabilities of multiple myeloma
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Raissa Kaori Ikeda, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3373-3390
Open Access | Times Cited: 10
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Raissa Kaori Ikeda, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3373-3390
Open Access | Times Cited: 10
Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels
Yogesh Chawla, Emilie I. Anderson, Matthew Smith, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access
Yogesh Chawla, Emilie I. Anderson, Matthew Smith, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access
Proteasome inhibition in multiple myeloma: lessons for other cancers
Paula Saavedra-García, Francesca Martini, Holger W. Auner
AJP Cell Physiology (2019) Vol. 318, Iss. 3, pp. C451-C462
Open Access | Times Cited: 29
Paula Saavedra-García, Francesca Martini, Holger W. Auner
AJP Cell Physiology (2019) Vol. 318, Iss. 3, pp. C451-C462
Open Access | Times Cited: 29
Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma
Wilson I. Gonsalves, Katarzyna A. Broniowska, Erik Jessen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Wilson I. Gonsalves, Katarzyna A. Broniowska, Erik Jessen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma
Timon A. Bloedjes, Guus de Wilde, Jeroen E. J. Guikema
Cancers (2021) Vol. 13, Iss. 3, pp. 396-396
Open Access | Times Cited: 23
Timon A. Bloedjes, Guus de Wilde, Jeroen E. J. Guikema
Cancers (2021) Vol. 13, Iss. 3, pp. 396-396
Open Access | Times Cited: 23
Source of nicotinamide governs its metabolic fate in cultured cells, mice, and humans
Tumpa Dutta, Nidhi Kapoor, Meril Mathew, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112218-112218
Open Access | Times Cited: 9
Tumpa Dutta, Nidhi Kapoor, Meril Mathew, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112218-112218
Open Access | Times Cited: 9
Metabolomic biomarkers of multiple myeloma: A systematic review
Valeria G. Varzieva, Natalia V. Mesonzhnik, I. S. Ilgisonis, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189151-189151
Closed Access | Times Cited: 3
Valeria G. Varzieva, Natalia V. Mesonzhnik, I. S. Ilgisonis, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189151-189151
Closed Access | Times Cited: 3
In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells
Wilson I. Gonsalves, Jin Sung Jang, Erik Jessen, et al.
Cancer & Metabolism (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Wilson I. Gonsalves, Jin Sung Jang, Erik Jessen, et al.
Cancer & Metabolism (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 21